Is C-reactive protein (CRP) elevated in vasculitis?

CRP is Typically Elevated in Vasculitis

Yes, C-reactive protein (CRP) is characteristically elevated in active vasculitis and serves as a key inflammatory marker for disease monitoring, though the degree of elevation varies by vasculitis type. 1

CRP as a Diagnostic and Monitoring Tool

Large Vessel Vasculitis (Giant Cell Arteritis and Takayasu Arteritis)

• CRP elevation is expected in active disease and should prompt urgent specialist referral when accompanied by suggestive symptoms 1
• The 2018 EULAR guidelines explicitly recommend regular monitoring using ESR/CRP levels as primary indicators of disease activity 1
• Patients with typical GCA symptoms and increased CRP/ESR presenting with acute visual disturbance should receive immediate treatment before diagnostic confirmation 1

Important caveat: The 2021 ACR/Vasculitis Foundation guidelines note that increases in CRP alone (without clinical symptoms) can be non-specific and do not warrant escalation of immunosuppressive therapy 2. This requires clinical observation and monitoring rather than automatic treatment intensification.

ANCA-Associated Vasculitis (AAV)

CRP elevation in AAV has more complex implications:

• CRP is commonly elevated at disease onset and correlates with severe disease manifestations including critical illness and severe kidney dysfunction 3
• A discordant pattern of low ESR/high CRP predicts worse outcomes, including significantly higher mortality rates compared to other inflammatory marker patterns 4
• High CRP at baseline specifically correlates with active lesions, particularly interstitial arteritis in MPO-ANCA positive patients 3

Clinical Significance Beyond Simple Inflammation

Recent evidence suggests CRP plays an active pathogenic role rather than serving as merely a passive marker:

• CRP can enhance neutrophil respiratory burst induced by ANCA, potentially amplifying vascular injury 5
• Monomeric CRP activates platelets to release mitochondrial DNA, which further enhances ANCA-mediated neutrophil activation 6

Historical Validation

A landmark 1985 prospective study established that CRP concentration is always elevated in active necrotizing systemic vasculitis and falls rapidly with clinical remission 7. This study demonstrated CRP responds more rapidly to disease activity changes than ESR, making it superior for real-time disease monitoring.

Practical Monitoring Algorithm

1. At presentation: Elevated CRP + suggestive symptoms → urgent specialist referral
2. During treatment: Falling CRP → confirms therapeutic response
3. In remission: Normal CRP expected; isolated elevation without symptoms → observe, do not escalate therapy 2
4. Pattern recognition: Low ESR/high CRP in AAV → indicates higher risk disease requiring closer monitoring 4

Critical pitfall: Do not treat isolated CRP elevations without corresponding clinical evidence of active disease, as this leads to unnecessary immunosuppression exposure 2.